参考文献/References:
[1] Di Mario C,Werner GS,Sianos Get al. European perspective in the recanalisation of Chronic Total Occlusions (CTO):consensus document from the EuroCTO Club[J]. EuroIntervention,2007,3(1):30-43.
[2] Sianos G,Werner GS,Galassi AR,et al. Recanalisation of chronic total coronary occlusions:2012 consensus document from the EuroCTO club[J]. EuroIntervention,2012,8(1):139-145.
[3] Karmpaliotis D,Karatasakis A,Alaswad K,et al. Outcomes with the use of the retrograde approach for coronary chronic total occlusion interventions in a contemporary multicenter US Registry[J]. Circ Cardiovasc Interv,2016,9(6):10.1161/CIRCINTERVENTIONS.115.003434 e003434.
[4] Tomasello SD,Boukhris M,Giubilato S,et al. Management strategies in patients affected by chronic total occlusions:results from the Italian Registry of Chronic Total Occlusions[J]. Eur Heart J,2015,36(45):3189-3198.
[5] R?munddal T,Hoebers LP,Hoebers L,et al. Chronic total occlusions in Sweden—A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)[J]. PLoS One,2014,9(8):e103850.
[6] Claessen BE,van der Schaaf RJ,Verouden NJ,et al. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention[J]. JACC Cardiovasc Interv,2009,2(11):1128-1134.
[7] Azzalini L,Vo M,Dens J,et al. Myths to debunk to improve management,referral,and outcomes in patients with chronic total occlusion of an epicardial coronary artery[J]. Am J Cardiol,2015,116(11):1774-1780.
[8] Safley DM,Koshy S,Grantham JA,et al. Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions[J]. Catheter Cardiovasc Interv,2011,78(3):337-343.
[9] Rossello X,Pujadas S,Serra A,et al. Assessment of inducible myocardial ischemia,quality of life,and functional status after successful percutaneous revascularization in patients with chronic total coronary occlusion[J]. Am J Cardiol,2016,117(5):720-726.
[10] Safley DM,Grantham JA,Hatch J,et al. Quality of life benefits of percutaneous coronary intervention for chronic occlusions[J]. Catheter Cardiovasc Interv,2014,84(4):629-634.
[11] Galassi AR,Werner GS,Boukhris M,et al. Percutaneous recanalisation of chronic total occlusions:2019 consensus document from the EuroCTO Club[J]. EuroIntervention,2019,15(2):198-208.
[12] Azzalini L,Jolicoeur EM,Pighi M,et al. Epidemiology,Management Strategies,and Outcomes of Patients With Chronic Total Coronary Occlusion[J]. Am J Cardiol,2016,118(8):1128-1135.
[13] Bhatnagar UB,Shrestha A,Petrasko M,et al. Current evidence and rationale of percutaneous therapy for chronic total coronary occlusions[J]. Curr P robl C ardiol,2019,44(12):100412.
[14] 白海渊,脱军运,王志禄.冠状动脉慢性完全闭塞病变的临床研究进展[J]. 中华老年心脑血管病杂志,2015,17(9):990-993.
[15] 安明春,杨旭明.冠状动脉慢性完全闭塞病变介入治疗及临床获益研究进展[J]. 心血管病学进展,2019,40(6):860-864.
[16] Neumann FJ,Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)[J]. G Ital Cardiol (Rome).,2019,20(7-8 Suppl 1):1S-61S.
[17] Christakopoulos GE,Christopoulos G,Carlino M,et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions[J]. Am J Cardiol,2015,115(10):1367-1375.
[18] Lee PH,Lee SW,Park HS,et al. Successful recanalization of native coronary chronic total occlusion is not associated with improved long-term survival[J]. JACC Cardiovasc Interv,2016,9(6):530-538.
[19] Werner GS,Martin-Yuste V,Hildick-Smith D,et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions[J]. Eur Heart J,2018,39(26):2484-2493.
[20] Henriques JP,Hoebers LP,R?munddal T,et al. Percutaneous Intervention for Concurrent?Chronic Total Occlusions in?Patients With?STEMI:The EXPLORE Trial[J]. J Am Coll Cardiol,2016,68(15):1622-1632.
[21] Sachdeva R,Agrawal M,Flynn SE,et al. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone[J]. Catheter Cardiovasc Interv,2014,83(1):9-16.
[22] Werner GS,Ferrari M,Heinke S,et al. Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions[J]. Circulation,2003,107(15):1972-1977.
相似文献/References:
[1]安明春,杨旭明.冠状动脉慢性完全闭塞病变介入治疗及临床获益研究进展[J].心血管病学进展,2019,(6):860.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.006]
AN Mingchun,YANG Xuming.Research Progress in Interventional Therapy and Clinical Benefits of CTO Lesions[J].Advances in Cardiovascular Diseases,2019,(8):860.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.006]
[2]范子胤 彭瑜 张钲.心肌梗死相关性心源性休克血运重建的研究进展[J].心血管病学进展,2021,(5):417.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.008]
FAN Ziyin,PENG Yu,ZHANG Zheng.Revascularization of Myocardial Infarction Associated Cardiogenic Shock[J].Advances in Cardiovascular Diseases,2021,(8):417.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.008]
[3]马兴鸿 汪蕾 方纬.核素心肌显像在冠状动脉慢性完全闭塞临床诊疗中的应用价值[J].心血管病学进展,2022,(4):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
MA Xinghong,WANG Lei,FANG Wei.Application Value of Radionuclide Myocardial Imaging In the Clinical Diagnosis And Treatment of Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2022,(8):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
[4]韩旭 汪蕾 方纬.18F-FDG PET评估存活心肌指导冠状动脉血运重建治疗的研究进展[J].心血管病学进展,2023,(1):11.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.004]
HAN Xu,WANG Lei,FANG Wei.Coronary Revascularization Therapy Guided by 18F-FDG PET in Evaluating Viable Myocardium[J].Advances in Cardiovascular Diseases,2023,(8):11.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.004]
[5]李婕 李晓梅.血流储备分数及其衍生指标在急性冠脉综合征中的临床应用[J].心血管病学进展,2023,(1):44.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.011]
LI Jie,LI Xiaomei.Clinical Application of Fractional Flow Reserve and Its Derived Indicators in Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2023,(8):44.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.011]
[6]张颖 集铄媛 谷国强.冠状动脉慢性完全闭塞正向介入治疗技术进展[J].心血管病学进展,2023,(2):122.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.006]
ZHANG Ying,JI Shuoyuan,GU Guoqiang.Antegrade Approach to Percutaneous Coronary Intervention for Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2023,(8):122.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.006]
[7]卡迪热亚·木它里甫 刘凯.肾动脉粥样硬化性狭窄诊治进展[J].心血管病学进展,2023,(7):589.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.004]
Kadireya·Mutalifu LIU Kai.Advances in Treatment and Diagnosis for Atherosclerotic Renal Artery Stenosis[J].Advances in Cardiovascular Diseases,2023,(8):589.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.004]
[8]王章龙 刘瑞麟 张波 周敬群.非罪犯血管病变的评估及其在血运重建中的作用[J].心血管病学进展,2023,(9):845.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.018]
WANG Zhanglong,LIU Ruilin,ZHANG Bo,et al.Evaluation of Non-Culprit Coronary Lesions and Its Role in Revascularization[J].Advances in Cardiovascular Diseases,2023,(8):845.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.018]